Addressing the challenge of platinum-resistant ovarian cancer: the role of mirvetuximab soravtansine

被引：0
作者：
Shaukat, Ayesha [1 ]
Shakeel, Laiba [1 ]
Khan, Afsheen [1 ]
Irfan, Hamza [2 ]
Akilimali, Aymar [3 ]
机构：
[1] Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan
[2] Shaikh Khalifa Bin Zayed Al Nahyan Med & Dent Coll, Dept Internal Med, Lahore, Pakistan
[3] Med Res Circle, Dept Res, Goma, DEM REP CONGO
来源：
ANNALS OF MEDICINE AND SURGERY | 2025年 / 87卷 / 01期
关键词：
EXPRESSION; CISPLATIN; WOMEN;
D O I：
10.1097/MS9.0000000000002759
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [31] Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition
    Xu, Manman
    Huang, Xi
    Zheng, Cuimiao
    Long, Junming
    Dai, Qingyuan
    Chen, Yangyang
    Lu, Jingyi
    Pan, Chaoyun
    Yao, Shuzhong
    Li, Jie
    CANCERS, 2022, 14 (24)
  • [32] Clinical Response to Antiestrogen Therapy in Platinum-Resistant Ovarian Cancer Patients and the Role of Tumor Estrogen Receptor Expression Status
    Stasenko, Marina
    Plegue, Melissa
    Sciallis, Andrew P.
    McLean, Karen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (02) : 222 - 228
  • [33] Cranberry Proanthocyanidins are Cytotoxic to Human Cancer Cells and Sensitize Platinum-Resistant Ovarian Cancer Cells to Paraplatin
    Singh, Ajay P.
    Singh, Rakesh K.
    Kim, Kyu Kwang
    Satyan, K. S.
    Nussbaum, Roger
    Torres, Monica
    Brard, Laurent
    Vorsa, Nicholi
    PHYTOTHERAPY RESEARCH, 2009, 23 (08) : 1066 - 1074
  • [34] Pegylated liposomal doxorubicin in partially platinum-sensitive, platinum-resistant, or platinum-refractory ovarian cancer: a prospective study
    Zhang, Ying
    Yuan, Zhen
    Zhang, Guo-Nan
    Li, Qing-Shui
    Cui, Man-Hua
    Cheng, Wen-Jun
    Meng, Yuan-Guang
    Wu, Xiao-Hua
    Yue, Ying
    Wang, Li
    Hou, Jian-Qing
    Li, Chang-Zhong
    Qu, Peng-Peng
    Sun, Li-Xin
    Tao, Guang-Shi
    Li, Gui-Ling
    Chen, Ya-Qing
    Ren, Fang
    Cao, Dong-Yan
    Shen, Keng
    ONCOLOGIST, 2024,
  • [35] Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
    Nakka, Thejeswar
    Goenka, Luxitaa
    Dubashi, Biswajit
    Kayal, Smita
    Mathaiyan, Jayanthi
    Barathi, Deepak
    Krishnamoorthy, Narendran
    Thumaty, Divya Bala
    Dahagama, Sindhu
    Ganesan, Prasanth
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [36] Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer
    Lowery, William J.
    Lowery, Ashlei W.
    Barnett, Jason C.
    Lopez-Acevedo, Micael
    Lee, Paula S.
    Secord, Angeles Alvarez
    Havrilesky, Laura
    GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 426 - 430
  • [37] Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer
    Knisely, Anne
    Hinchcliff, Emily M.
    Gardiner, Elisabeth
    Rangwala, Reshma
    Lito, Kathryn
    Fellman, Bryan
    Yuan, Ying
    Sood, Anil K.
    Westin, Shannon N.
    Lu, Karen H.
    Jazaeri, Amir A.
    ISCIENCE, 2024, 27 (05)
  • [38] Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer
    Yeku, Oladapo O.
    Barve, Minal
    Tan, Winston W.
    Wang, Judy
    Patnaik, Amita
    Lorusso, Patricia
    Richardson, Debra L.
    Naqash, Abdul Rafeh
    Lynam, Sarah K.
    Fu, Siqing
    Gordon, Michael
    Hubbard, Joleen
    Kummar, Shivaani
    Kyriakopoulos, Christos
    Dowlati, Afshin
    Chamberlain, Marc
    Winer, Ira
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [39] The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
    Barber, Emma L.
    Zsiros, Emese
    Lurain, John R.
    Rademaker, Alfred
    Schink, Julian C.
    Neubauer, Nikki L.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (03) : 258 - 264
  • [40] Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer
    Karaoglu, Aziz
    Arslan, Ulku Yalcintas
    Ozkan, Metin
    Kalender, Mehmet Emin
    Alici, Suleyman
    Coskun, Ugur
    Gumus, Mahmut
    Celenkoglu, Gokhan
    Er, Ozlem
    Sevinc, Alper
    Buyukberber, Suleyman
    Alkis, Necati
    Benekli, Mustafa
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (01) : 63 - 66
12345